Analyze Diet
Journal of veterinary pharmacology and therapeutics2016; 40(4); 335-341; doi: 10.1111/jvp.12366

Comparative pharmacokinetics of minocycline in foals and adult horses.

Abstract: The objective of this study was to compare the pharmacokinetics of minocycline in foals vs. adult horses. Minocycline was administered to six healthy 6- to 9-week-old foals and six adult horses at a dose of 4 mg/kg intragastrically (IG) and 2 mg/kg intravenously (i.v.) in a cross-over design. Five additional oral doses were administered at 12-h intervals in foals. A microbiologic assay was used to measure minocycline concentration in plasma, urine, synovial fluid, and cerebrospinal fluid (CSF). Liquid chromatography-tandem mass spectrometry was used to measure minocycline concentrations in pulmonary epithelial lining fluid (PELF) and bronchoalveolar (BAL) cells. After i.v. administration to foals, minocycline had a mean (±SD) elimination half-life of 8.5 ± 2.1 h, a systemic clearance of 113.3 ± 26.1 mL/h/kg, and an apparent volume of distribution of 1.24 ± 0.19 L/kg. Pharmacokinetic variables determined after i.v. administration to adult horses were not significantly different from those determined in foals. Bioavailability was significantly higher in foals (57.8 ± 19.3%) than in adult horses (32.0 ± 18.0%). Minocycline concentrations in PELF were higher than in other body fluids. Oral minocycline dosed at 4 mg/kg every 12 h might be adequate for the treatment of susceptible bacterial infections in foals.
Publication Date: 2016-09-29 PubMed ID: 27682322DOI: 10.1111/jvp.12366Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The study presents a comparison of how the antibiotic minocycline behaves in the body (its pharmacokinetics) of foals and adult horses, finding a higher absorption of the drug in foals compared to adults when given orally. Also, it suggests a dosage that could be beneficial for treating bacterial infections in foals.

Design and Methodology

  • This study involved six healthy 6- to 9-week-old foals and six adult horses. Minocycline, an antibiotic, was given to these participants.
  • The antibiotic was administered intragastrically (IG or into the stomach) and intravenously (i.v. or into the vein).
  • The dosage for intragastric administration was 4 mg/kg, and for intravenous, it was 2 mg/kg.
  • For foals, five additional oral doses were administered at 12-hour intervals, which was not specified for adult horses.
  • The researchers then measured the concentration of minocycline in various body fluids such as plasma, urine, synovial fluid, and cerebrospinal fluid (CSF) using a microbiological assay.
  • Minocycline concentrations in pulmonary epithelial lining fluid (PELF) and bronchoalveolar (BAL) cells were measured using liquid chromatography-tandem mass spectrometry.

Results

  • The elimination half-life of minocycline in foals, after i.v. administration, was 8.5 ± 2.1 hours. The systemic clearance was 113.3 ± 26.1 mL/h/kg and the apparent volume of distribution was 1.24 ± 0.19 L/kg.
  • The same variables, when determined in adult horses, were not significantly different from those in foals.
  • The bioavailability of minocycline, which refers to the percentage of the drug that enters the circulation and can have an active effect, was significantly higher in foals (57.8 ± 19.3%) than in adult horses (32.0 ± 18.0%). This indicates that the drug is absorbed more effectively in foals when administered orally.
  • The concentration of minocycline in PELF was higher than in other body fluids. This could indicate the drug’s significant presence in the respiratory tract, potentially making it effective for respiratory infections.
  • The study concludes that an oral dosage of minocycline at 4 mg/kg every 12 hours might be suitable for treating susceptible bacterial infections in foals.

Cite This Article

APA
Giguère S, Burton AJ, Berghaus LJ, Haspel AD. (2016). Comparative pharmacokinetics of minocycline in foals and adult horses. J Vet Pharmacol Ther, 40(4), 335-341. https://doi.org/10.1111/jvp.12366

Publication

ISSN: 1365-2885
NlmUniqueID: 7910920
Country: England
Language: English
Volume: 40
Issue: 4
Pages: 335-341

Researcher Affiliations

Giguère, S
  • Department of Large Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens, GA, USA.
Burton, A J
  • Department of Large Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens, GA, USA.
Berghaus, L J
  • Department of Large Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens, GA, USA.
Haspel, A D
  • Department of Large Animal Medicine, College of Veterinary Medicine, University of Georgia, Athens, GA, USA.

MeSH Terms

  • Animals
  • Animals, Newborn
  • Anti-Bacterial Agents / administration & dosage
  • Anti-Bacterial Agents / pharmacokinetics
  • Body Fluids
  • Drug Administration Routes / veterinary
  • Half-Life
  • Horses / metabolism
  • Injections, Intravenous / veterinary
  • Minocycline / administration & dosage
  • Minocycline / pharmacokinetics
  • Synovial Fluid

Citations

This article has been cited 4 times.
  1. Zheng X, Yang N, Mao R, Hao Y, Teng D, Wang J. Pharmacokinetics and Pharmacodynamics of Fungal Defensin NZX Against Staphylococcus aureus-Induced Mouse Peritonitis Model. Front Microbiol 2022;13:865774.
    doi: 10.3389/fmicb.2022.865774pubmed: 35722282google scholar: lookup
  2. Erol E, Scortti M, Fortner J, Patel M, Vázquez-Boland JA. Antimicrobial Resistance Spectrum Conferred by pRErm46 of Emerging Macrolide (Multidrug)-Resistant Rhodococcus equi. J Clin Microbiol 2021 Sep 20;59(10):e0114921.
    doi: 10.1128/JCM.01149-21pubmed: 34319806google scholar: lookup
  3. Ma X, Aminov R, Franco OL, de la Fuente-Nunez C, Wang G, Wang J. Editorial: Antimicrobial peptides and their druggability, bio-safety, stability, and resistance. Front Microbiol 2024;15:1425952.
    doi: 10.3389/fmicb.2024.1425952pubmed: 38846567google scholar: lookup
  4. Scantamburlo G, Nofziger C, Paulmichl M, Vanoni S. Genetic analysis of the equine orthologues for human CYP2D6: unraveling the complexity of the CYP2D family in horses. Front Vet Sci 2023;10:1188633.
    doi: 10.3389/fvets.2023.1188633pubmed: 37929279google scholar: lookup